SUPREME COURT TO RULE ON DRUGMAKERS' DUTY TO DISCLOSE ‘ADVERSE EVENTS' Matrixx Initiatives v. Siracusano | Secondary Sources | Westlaw

SUPREME COURT TO RULE ON DRUGMAKERS' DUTY TO DISCLOSE ‘ADVERSE EVENTS' Matrixx Initiatives v. Siracusano | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, SUPREME COURT TO RULE ON DRUGMAKERS' DUTY TO DISCLOSE ‘ADVERSE EVENTS' Matrixx Initiatives v. Siracusano, Secondary Sources
Skip Page Header

SUPREME COURT TO RULE ON DRUGMAKERS' DUTY TO DISCLOSE ‘ADVERSE EVENTS' Matrixx Initiatives v. Siracusano

26 No. 14 WJCODL 9Westlaw Journal Corporate Officers & Directors Liability (Approx. 4 pages)

SUPREME COURT TO RULE ON DRUGMAKERS' DUTY TO DISCLOSE ‘ADVERSE EVENTS' Matrixx Initiatives v. Siracusano

26 No. 14 WJCODL 9Westlaw Journal Corporate Officers & Directors Liability (Approx. 4 pages)

26 No. 14 Westlaw Journal Corporate Officers & Directors Liability 9
Westlaw Journal Corporate Officers & Directors Liability
*1 January 3, 2011
Securities Fraud
Copyright © 2011 Thomson Reuters .

SUPREME COURT TO RULE ON DRUGMAKERS' DUTY TO DISCLOSE ‘ADVERSE EVENTS'

Matrixx Initiatives v. Siracusano

Briefs and Other Related Documents
The U.S. Supreme Court is set to hear arguments in a securities fraud case that has the pharmaceutical industry alarmed over the prospect of having to disclose to investors so-called “adverse event reports” even when they are statistically trivial....
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.